Emerald Health: Q2 ’19
Included in this report:
• Cannin Tools
• Market & Industry Update
• Fundamental Analysis (Emerald Health)
• Medical Research
• Cannabis Terminology
• Hemp Infographic
• Industry Terminology
About Emerald Health
Primary: Production and sales of cannabis in Canada. Later, broader markets, such as Europe. Emerald is science focused, is developing proprietary genetics, has PhD scientists and big-Pharma vets in senior management. Management is interested in the economic potential of CBD.
Secondary: Through the University of British Columbia, it is studying treatments of neurodegenerative and neuroinflammatory diseases, as well as metabolic and other diseases.
Search Cannabis and Hemp Stocks
- HempFusion: Is this Hemp Stock Still a Buy?
- Should You Buy Cronos Stock After its Q4 Earnings?
- Aphria: Is this Cannabis Stock Still a Buy?
- Top 3 Hemp Stocks to Watch in 2021
- Best Cannabis Stock for 2021: GrowGeneration
- 3 Strong Buy and Hold Cannabis Stocks for 2021
- Village Farms: Perfect Hemp Stock Pick for Your Portfolio?
Cannabis Stock Watchlist
|Symbol||Last Price||% Change|
Search for Specific Hemp and Cannabis Stocks
From the Cannin Community
"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"